
A. Michael Lincoff, MD
Interventional Cardiologists
Speciality
Interventional CardiologistAbout
A. Michael Lincoff, MD, is Vice Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine and an interventional cardiologist in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic.
He supervises clinical research activities throughout the Cleveland Clinic as Director of the Center for Clinical Research of the Lerner Research Institute. Dr. Lincoff is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), an academic research organization that plans, coordinates and manages multicenter clinical trials of new pharmacologic or device therapies.
Dr. Lincoff’s research activities focus on development of therapies to reduce acute and long-term complications of percutaneous coronary revascularization procedures, to optimize therapy for acute coronary ischemic syndromes or reduce progression or complications of atherosclerosis. He has served as principal investigator or steering committee member of over 15 pivotal trials in ischemic heart disease, enrolling in aggregate over 50,000 patients, studying new antiplatelet or antithrombotic agents in the settings of coronary intervention, heart attack or unstable angina.
Dr. Lincoff is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds the Charles and Charlotte Fowler Endowed Chair for Cardiovascular Research at Cleveland Clinic.
Dr. Lincoff has authored or coauthored over 200 peer-reviewed articles, including publications in the New England Journal of Medicine, Journal of the American Medical Association, Lancet, Annals of Internal Medicine, Circulation, Journal of the American College of Cardiology, American Heart Journal and European Heart Journal. He is editor of a book entitled Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, now in its second edition. He has also authored over 80 book chapters and reviews and presented over 300 lectures at various medical meetings and courses throughout the world. He is the Consulting Editor of the American Journal of Cardiovascular Drugs and serves on editorial boards or as a reviewer for over 15 peer-reviewed scientific journals.
Dr. Lincoff is currently chairman of the Cardiovascular and Renal Drugs Advisory Committee of the United States Food and Drug Administration.
Dr. Lincoff is a fellow of the American College of Cardiology and the European Society of Cardiology and a member of the American College of Physicians, scientific councils of the American Heart Association and the Sigma Xi Scientific Research Society.
Treatment & Services
- Abnormal Stress Test
- Angiography
- Angioplasty
- Atherectomy
- Cardiovascular Medicine
- Cardiovascular Medicine Department
- Clinical Trials
- Coronary Balloon Angioplasty (PTCA)
- Coronary Intervention
- Drug Eluting Stenting
Specialty in Diseases & Conditions
- Angina
- Bifurcation Blockage
- Coronary Artery Disease
- Heart Attack
- Ischemic Cardiomyopathy
- Restenosis
Education & Professional Highlights
Appointed
1994
Fellowship - Cleveland Clinic
Interventional Cardiology
Cleveland, OH USA
1993
Fellowship - Cleveland Clinic
Cardiovascular Disease
Cleveland, OH USA
1992
Fellowship - University of Michigan Health System
Cardiovascular Medicine
Ann Arbor, MI USA
1991
Residency - Beth Israel Deaconess Medical Center and Harvard Medical School
Internal Medicine
Boston, MA USA
1989
Internship - Beth Israel Deaconess Medical Center and Harvard Medical School
Medical Internship
Boston, MA USA
1987
Medical Education - Johns Hopkins University School of Medicine
Baltimore, MD USA
1986
Undergraduate - Carnegie Mellon University
Chemical/Biomed. Engineering
Pittsburgh, PA USA
1982
Professional Highlights
- Director, Center for Clinical Research and Vice Chairman for Clinical Research of the Cleveland Clinic Lerner Research Institute
- Director, Cleveland Clinic Coordinating Center for Clinical Research (C5Research)
- Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic
- Charles and Charlotte Fowler Endowed Chair in Cardiovascular Research, Cleveland Clinic
Hospital Affiliations
Cleveland ClinicCleveland, OHCertifications & Licensure
American Board of Internal Medicine
Certified in Cardiovascular Disease
American Board of Internal Medicine
Certified in Internal Medicine
American Board of Internal Medicine
Certified in Interventional Cardiology
MA State Medical License
Active through 2000
MI State Medical License
Active through 1992
OH State Medical License
Active through 2024
Awards, Honors, & Recognition
- Maria and Sam Miller Professional Excellence Award - Scientific Achievement Award in Clinical ResearchCleveland Clinic Foundation, 2012
- CMS Meaningful Use Stage 1 CertificationEpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- American College of Cardiology/Bristol Laboratories Affiliate Travel AwardCleveland Clinic Foundation, 1993
Memberships
- American College of Cardiology
- European Society of Cardiology
- American College of Physicians
- American Heart Association
- Sigma Xi Research Society
Publications
- Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.
Guillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, Steven L Zelenkofske, A Michael Lincoff, Roxana Mehran, P Gabriel Steg, Christoph Bode, John H Alexand...> ;Journal of the American Heart Association. 2023 Jan 3 - 1 citations
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.
Ildiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, John Deanfield, Scott S Emerson, Sille Esbjerg, Søren Hardt-Lindberg, G Kees Hovingh, Steven E Kahn, Robert F...> ;Obesity. 2023 Jan 1 - Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary Intervention.
Anirudh Kumar, Gregory O Ogunnowo, Umesh N Khot, Claire E Raphael, Joanna Ghobrial, Penelope Rampersad, Rishi Puri, Jaikirshan J Khatri, Grant W Reed, Amar Krishnaswam...> ;Journal of the American Heart Association. 2022 Nov 15